Document is current
Any future updates will be listed below
-
Authors
Lal, Jessica Castrillon
Townsend, Madeline G.
Mehta, Anita K.
Oliwa, Madisson
Miller, Eric
Sotayo, Alaba
Cheney, Emily
Mittendorf, Elizabeth A.
Letai, Anthony
Guerriero, Jennifer L. http://orcid.org/0000-0002-2104-5457
-
Funding
Funding for this research was provided by:
National Institutes of Health (SPORE 5P50CA168504)
Susan G. Komen for the Cure (CCR18547597)
Ludwig Center at Harvard
- License Information
-
More Information
Article History
Received: 22 July 2020
Accepted: 22 June 2021
First Online: 5 August 2021
Declarations
:
: All mice were maintained within the Dana-Farer Cancer Center (DFCI), and all experiments were conducted under The Institutional Animal Care and Use Committee (IACUC).
: n/a
: J.L.G. is a consultant for Glaxo-Smith Kline (GSK), Array BioPharma, Codagenix, and Verseau and receives sponsored research support from GSK, Eli Lilly, and Array BioPharma. E.A.M has served on SABs for Astra-Zeneca/Medimmune, Celgene, Genentech, Genomic Health, Merck, Peregrine Pharmaceuticals, SELLAS Lifescience, and Tapimmune and has clinical trial support to her former institution (MDACC) from astra-zeneca/Medimmune, EMD-Serono, Galena Biopharma, and Genentech as well as Genentech support to a SU2C grant, as well as sponsored Research Support to the laboratory from GSK and Eli Lilly. A.L. is a consultant for Astra-Zeneca, receives sponsored research support from Novartis, and serves on the scientific advisory board for Flash Therapeutics, Zentalis, and Dialectic. E.M. is an employee and stockholder of NanoString Technologies.
